BORTZ GREGORY M. 4
4 · ENZO BIOCHEM INC · Filed Nov 2, 2017
Insider Transaction Report
Form 4
BORTZ GREGORY M.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-10-31$2.88/sh+59,455$171,230→ 292,875 total - Sale
Common Stock
2017-10-31$9.82/sh−42,005$412,489→ 250,870 total - Exercise/Conversion
Stock Option (to acquire common stock)
2017-10-31$2.88/sh−59,455$171,230→ 239,632 totalExercise: $2.88From: 2014-01-17Exp: 2018-01-17→ Common Stock (59,455 underlying)
Footnotes (2)
- [F1]Represents shares sold to cover the exercise price of the Stock Options and shares sold to satisfy reporting person's tax obligations.
- [F2]The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.77 to $9.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.